secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2025-10-14T23:59:59+00:00
Accession:  0001213900-25-098421
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CERo Therapeutics raises up to $7M via Series E convertible preferred private placement
--------------------------------------------------------------------------------

- Initial closing of ~$1.8M; Series E convertible at $1,000 stated value, conversion price $4.1625 per share.
- Series C and D conversion price reduced to $1.76 as consent for pari passu treatment with Series E.
- Company to seek stockholder approval by Oct 31, 2025 for lower conversion; meeting target Dec 31, 2025.
- Bankruptcy trigger and company optional redemption each at 25% premium.
- Registration rights agreement filed to register resale of conversion shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025098421/0001213900-25-098421-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025098421/ea0260318-8k_cero.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-098421

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer